
James C. Yeung
Examiner (ID: 15138)
| Most Active Art Unit | 3406 |
| Art Unit(s) | 3401, 3749, 3105, 3743, 3404, 3405, 3406, 2899 |
| Total Applications | 2326 |
| Issued Applications | 2124 |
| Pending Applications | 58 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18271748
[patent_doc_number] => 20230092990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => MARKER AND PRODUCT FOR AUXILIARY DIAGNOSIS OF VALVULAR HEART DISEASE (VHD)
[patent_app_type] => utility
[patent_app_number] => 17/994029
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/994029 | MARKER AND PRODUCT FOR AUXILIARY DIAGNOSIS OF VALVULAR HEART DISEASE (VHD) | Nov 24, 2022 | Abandoned |
Array
(
[id] => 18470308
[patent_doc_number] => 20230204593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => MICROVESICLE HISTONE H2AX AS A BIOMARKER FOR GENOTOXIC STRESS
[patent_app_type] => utility
[patent_app_number] => 18/058683
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058683
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/058683 | MICROVESICLE HISTONE H2AX AS A BIOMARKER FOR GENOTOXIC STRESS | Nov 22, 2022 | Abandoned |
Array
(
[id] => 18377224
[patent_doc_number] => 20230152311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => Analyte Test Strip Assays, and Test Strips and Kits for Use in Practicing the Same
[patent_app_type] => utility
[patent_app_number] => 17/992664
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992664 | Analyte Test Strip Assays, and Test Strips and Kits for Use in Practicing the Same | Nov 21, 2022 | Abandoned |
Array
(
[id] => 18240450
[patent_doc_number] => 20230072761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Immunoassay for Detecting Zika Virus Infection
[patent_app_type] => utility
[patent_app_number] => 18/053028
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053028
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053028 | Immunoassay for Detecting Zika Virus Infection | Nov 6, 2022 | Abandoned |
Array
(
[id] => 18362369
[patent_doc_number] => 20230143960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => DEVICES AND METHODS FOR MESOFLUIDIC AND/OR MICROFLUIDIC PROCESSES
[patent_app_type] => utility
[patent_app_number] => 17/981943
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981943 | DEVICES AND METHODS FOR MESOFLUIDIC AND/OR MICROFLUIDIC PROCESSES | Nov 6, 2022 | Pending |
Array
(
[id] => 18498608
[patent_doc_number] => 20230221317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ESTIMATING CELLULAR POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/049596
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049596 | ESTIMATING CELLULAR POPULATIONS | Oct 24, 2022 | Abandoned |
Array
(
[id] => 18437478
[patent_doc_number] => 20230184773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHODS FOR ANALYSING A URINE SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/970775
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970775 | METHODS FOR ANALYSING A URINE SAMPLE | Oct 20, 2022 | Pending |
Array
(
[id] => 18212530
[patent_doc_number] => 20230058794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
[patent_app_type] => utility
[patent_app_number] => 17/962125
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962125 | System for detecting infection in synovial fluid | Oct 6, 2022 | Issued |
Array
(
[id] => 19905017
[patent_doc_number] => 12282019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Compositions and methods to detect gastrointestinal disease
[patent_app_type] => utility
[patent_app_number] => 17/957853
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 27
[patent_no_of_words] => 26043
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957853 | Compositions and methods to detect gastrointestinal disease | Sep 29, 2022 | Issued |
Array
(
[id] => 18278910
[patent_doc_number] => 20230094382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS AND DEVICES FOR DETERMINING A LEVEL OF A COMPLEMENT ACTIVATION PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/935767
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935767 | METHODS AND DEVICES FOR DETERMINING A LEVEL OF A COMPLEMENT ACTIVATION PRODUCT | Sep 26, 2022 | Pending |
Array
(
[id] => 19962749
[patent_doc_number] => 12332242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Method and device for discriminating between viral and bacterial infections
[patent_app_type] => utility
[patent_app_number] => 17/897026
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1347
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17897026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/897026 | Method and device for discriminating between viral and bacterial infections | Aug 25, 2022 | Issued |
Array
(
[id] => 19609528
[patent_doc_number] => 12158400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Encapsulated reagents and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/822475
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8264
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822475 | Encapsulated reagents and methods of use | Aug 25, 2022 | Issued |
Array
(
[id] => 18223703
[patent_doc_number] => 20230062697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
[patent_app_type] => utility
[patent_app_number] => 17/821951
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821951 | TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION | Aug 23, 2022 | Pending |
Array
(
[id] => 17991285
[patent_doc_number] => 20220357322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/870477
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/870477 | Methods and materials for identifying and treating autoimmune GFAP astrocytopathy | Jul 20, 2022 | Issued |
Array
(
[id] => 18254846
[patent_doc_number] => 20230081885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => BIOMARKERS FOR DIAGNOSING IMPLANT RELATED RISK OF IMPLANT REVISION DUE TO ASEPTIC LOOSENING
[patent_app_type] => utility
[patent_app_number] => 17/812537
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812537 | Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening | Jul 13, 2022 | Issued |
Array
(
[id] => 17931102
[patent_doc_number] => 20220326227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => IMMUNOCHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/851215
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851215 | IMMUNOCHROMATOGRAPHY | Jun 27, 2022 | Pending |
Array
(
[id] => 18308068
[patent_doc_number] => 20230111968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis
[patent_app_type] => utility
[patent_app_number] => 17/851613
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851613 | Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis | Jun 27, 2022 | Abandoned |
Array
(
[id] => 19475016
[patent_doc_number] => 12105095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Assay to detect and quantitate specific antibodies for various redox forms of HMGB1
[patent_app_type] => utility
[patent_app_number] => 17/848804
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 9844
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848804 | Assay to detect and quantitate specific antibodies for various redox forms of HMGB1 | Jun 23, 2022 | Issued |
Array
(
[id] => 19092053
[patent_doc_number] => 11953500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application
[patent_app_type] => utility
[patent_app_number] => 17/824162
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10057
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824162 | Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application | May 24, 2022 | Issued |
Array
(
[id] => 17838955
[patent_doc_number] => 20220276260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/745140
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745140 | GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES | May 15, 2022 | Abandoned |